Ultragenyx Pharmaceutical INC.
At a glance
Employees500+
In business sinceNot reported
HeadquartersNovato, CA
US patents26
SAM.gov UEIMS1ZFMTA7JH7
CAGE code6KD99
Incorporated inDE
LEI529900EV44GVDN1DCX77
Brands
This company sells these brands.
- therapies
- ultrarare genetic diseases
- exploring
- drug modalities
- studying
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
26 US patents granted 2014–2025, 13 of them in the five years to SEP 2025.
Pharmaceuticals 17Organic fine chemistry 6Biotechnology 3
- Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin dUS 12,358,976 · granted JUL 15, 2025
- Gene therapy constructs for treating Wilson diseaseUS 12,338,450 · granted JUN 24, 2025
- Engineered producer cell lines and methods of making and using the sameUS 12,018,288 · granted JUN 25, 2024
- Methods of heat inactivation of adenovirusUS 11,944,658 · granted APR 2, 2024
- Cell culture methods involving HDAC inhibitors or rep proteinsUS 11,898,170 · granted FEB 13, 2024
Newest 5 shown · Granted to Ultragenyx Pharmaceutical Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | Novato | CA | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.





